HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS): Study protocol for a hybrid 1 stepped-wedge cluster randomized trial.

Shannon M Christy, Lily Patel, Mariana Arevalo, Lindsay Fuzzell, Ashley Whitmer, Kea Turner, L Robert Gore, Katherine Chung-Bridges, Daniel Parras, Edelise Y Endemano, Naomi C Brownstein, Susan T Vadaparampil
Author Information
  1. Shannon M Christy: Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA; Morsani College of Medicine, University of South Florida, Tampa, FL, USA; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: Shannon.Christy@moffitt.org.
  2. Lily Patel: College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA.
  3. Mariana Arevalo: Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: Mariana.Arevalo@moffitt.org.
  4. Lindsay Fuzzell: Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: Lindsay.Fuzzell@moffitt.org.
  5. Ashley Whitmer: Non-Therapeutic Research Office, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: Ashley.Whitmer@moffitt.org.
  6. Kea Turner: Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA; Morsani College of Medicine, University of South Florida, Tampa, FL, USA. Electronic address: Kea.Turner@moffitt.org.
  7. L Robert Gore: Morsani College of Medicine, University of South Florida, Tampa, FL, USA; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: lgore@adena.org.
  8. Katherine Chung-Bridges: Health Choice Network, Inc., Miami, FL, USA. Electronic address: KChung@hcnetwork.org.
  9. Daniel Parras: Health Choice Network, Inc., Miami, FL, USA. Electronic address: DParras@HCNetwork.org.
  10. Edelise Y Endemano: Health Choice Network, Inc., Miami, FL, USA. Electronic address: EEndemano@HCNetwork.org.
  11. Naomi C Brownstein: Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA. Electronic address: brownstn@musc.edu.
  12. Susan T Vadaparampil: Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA; Morsani College of Medicine, University of South Florida, Tampa, FL, USA; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: Susan.Vadaparampil@moffitt.org.

Abstract

BACKGROUND: This protocol paper describes the overall design for HPV MISTICS, a multilevel intervention to increase human papillomavirus (HPV) vaccination initiation and completion rates among adolescents aged 11-17.
METHODS: We will conduct a hybrid type 1 implementation-effectiveness trial using a stepped-wedge cluster randomized trial in eight federally qualified health centers (FQHCs) in Florida. Intervention components target three levels: system, providers, and parents. Outcomes will be assessed using quantitative (e.g., vaccination data, survey data) and qualitative methods (e.g., staff and parent interviews). We expect to quantify changes in HPV vaccine series initiation and completion rates for adolescents ages 11-17 in the eight FQHCs. We have hypothesized a 20-percentage point increase in HPV vaccine series initiation and a 10-percentage point increase in series completion. We also anticipate being able to explore factors at the system, provider, and patient levels as potential covariates. Implementation outcomes, barriers, and facilitators identified in the study will help characterize the implementation process and inform potential future intervention scale-up.
RESULTS: The project is ongoing; effectiveness and implementation outcomes will be determined following project completion.
CONCLUSIONS: Findings will provide evidence of an equity-informed research design and implementation procedures that could help improve HPV vaccination rates in similar health systems.
CLINICAL TRIALS IDENTIFIER: NCT05677360 (date registered: 2022-12-22); https://clinicaltrials.gov/study/NCT05677360?lead=Moffitt%20Cancer%20Center%20&aggFilters=status:rec&page=2&rank=17.

Keywords

Associated Data

ClinicalTrials.gov | NCT05677360

References

  1. Pediatrics. 2017 Jan;139(1): [PMID: 27940512]
  2. Prev Med Rep. 2020 Aug 26;20:101188 [PMID: 32953426]
  3. Acad Pediatr. 2018 Mar;18(2S):S79-S84 [PMID: 29502642]
  4. J Fam Pract. 1994 Feb;38(2):166-71 [PMID: 8308509]
  5. N Engl J Med. 2019 Jul 11;381(2):104-106 [PMID: 31167045]
  6. Implement Sci. 2009 Aug 07;4:50 [PMID: 19664226]
  7. MMWR Morb Mortal Wkly Rep. 2016 Jul 08;65(26):661-6 [PMID: 27387669]
  8. Hum Vaccin Immunother. 2015;11(2):322-9 [PMID: 25692455]
  9. J Adolesc Health. 2015 May;56(5 Suppl):S40-6 [PMID: 25863554]
  10. Hum Vaccin Immunother. 2016 Jun 2;12(6):1566-88 [PMID: 26838959]
  11. Implement Sci Commun. 2024 Mar 22;5(1):28 [PMID: 38520032]
  12. BMJ. 2018 Nov 9;363:k1614 [PMID: 30413417]
  13. JAMA Pediatr. 2022 Feb 1;176(2):203-205 [PMID: 34779839]
  14. J Community Health. 2022 Feb;47(1):53-62 [PMID: 34333719]
  15. Implement Sci. 2017 Aug 29;12(1):108 [PMID: 28851459]
  16. MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116 [PMID: 32817598]
  17. Implement Sci. 2018 Mar 27;13(1):52 [PMID: 29587804]
  18. J Pediatr Health Care. 2018 Mar - Apr;32(2):119-132 [PMID: 28918994]
  19. Prev Chronic Dis. 2019 Jul 03;16:E85 [PMID: 31274411]
  20. Prev Med Rep. 2017 Apr 04;6:322-328 [PMID: 28451518]

Grants

  1. P30 CA076292/NCI NIH HHS
  2. UL1 TR001450/NCATS NIH HHS

MeSH Term

Adolescent
Child
Female
Humans
Male
Florida
Papillomavirus Infections
Papillomavirus Vaccines
Parents
Research Design
Randomized Controlled Trials as Topic

Chemicals

Papillomavirus Vaccines

Word Cloud

Created with Highcharts 10.0.0HPVwilltrialcompletionprotocoldesigninterventionincreasevaccinationinitiationratesrandomizedvaccineseriesimplementationMISTICSadolescents11-17hybrid1implementation-effectivenessusingstepped-wedgeclustereighthealthFQHCsInterventionsystemegdatapointpotentialoutcomeshelpprojectMultilevelStudyBACKGROUND:paperdescribesoverallmultilevelhumanpapillomavirusamongagedMETHODS:conducttypefederallyqualifiedcentersFloridacomponentstargetthreelevels:providersparentsOutcomesassessedquantitativesurveyqualitativemethodsstaffparentinterviewsexpectquantifychangesageshypothesized20-percentage10-percentagealsoanticipateableexplorefactorsproviderpatientlevelscovariatesImplementationbarriersfacilitatorsidentifiedstudycharacterizeprocessinformfuturescale-upRESULTS:ongoingeffectivenessdeterminedfollowingCONCLUSIONS:Findingsprovideevidenceequity-informedresearchproceduresimprovesimilarsystemsCLINICALTRIALSIDENTIFIER:NCT05677360dateregistered:2022-12-22https://clinicaltrialsgov/study/NCT05677360?lead=Moffitt%20Cancer%20Center%20&aggFilters=status:rec&page=2&rank=17StrategiesTargetingImmunizationCommunitySettings:ClusterHybridStepped-wedge

Similar Articles

Cited By

No available data.